« Previous
Next »
Radiotherapy & Oncology
Volume 93, Issue 3
, Pages 618-624
, December 2009
DCEMRI of spontaneous canine tumors during fractionated radiotherapy: A pharmacokinetic analysis
References
- Molecular (functional) imaging for radiotherapy applications: an RTOG symposium. Int J Radiat Oncol Biol Phys. 2003;55:294–301
- . Beyond detection: novel applications for PET imaging to guide cancer therapy. J Nucl Med. 2007;48:855–856
- . Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging. 2002;16:407–422
- . PET for response assessment in oncology: radiotherapy and chemotherapy. Br J Radiol. 2005;S28:42–47
- . Radiotherapy adapted to spatial and temporal variability in tumor hypoxia. Int J Radiat Oncol Biol Phys. 2007;68:1496–1504
- . Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy. Lancet Oncol. 2007;8:63–74
- . Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2003;17:509–520
- . Imaging tumor vascular heterogeneity and angiogenesis using dynamic contrast-enhanced magnetic resonance imaging. Clin Cancer Res. 2007;13:3449–3459
- . Quantitation of blood–brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med. 1990;16:117–131
- . Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621–628
- . Measurement of the blood–brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17:357–367
- . DCEMRI monitoring of canine tumors during fractionated radiotherapy. Acta Oncol. 2008;47:1249–1256
- . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91–101
- Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223–232
- . Multicompartment analysis of gadolinium chelate kinetics: blood–tissue exchange in mammary tumors as monitored by dynamic MR imaging. J Magn Reson Imaging. 1999;10:233–241
- . Measuring the arterial input function with gradient echo sequences. Magn Reson Med. 2003;49:1067–1076
- Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome. Clin Cancer Res. 1998;4:2305–2312
- Prediction of radiotherapy outcome using dynamic contrast enhanced MRI of carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 2002;54:759–767
- Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys. 2009;74:766–773
- Intracranial meningiomas: time- and dose-dependent effects of irradiation on tumor microcirculation monitored by dynamic MR imaging. Magn Reson Imaging. 1997;15:423–432
- Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience. J Magn Reson Imaging. 2008;27:1296–1301
- Quantifying heterogeneity in dynamic contrast-enhanced MRI parameter maps. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv. 2007;10:376–384
- Tumor microcirculation evaluated by dynamic magnetic resonance imaging predicts therapy outcome for primary rectal carcinoma. Cancer Res. 2001;61:2513–2516
PII: S0167-8140(09)00448-4
doi: 10.1016/j.radonc.2009.08.012
© 2009 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Radiotherapy & Oncology
Volume 93, Issue 3
, Pages 618-624
, December 2009
